LDC-1267

N/A

Report date: 2022/02/18 14:24:03

Base Information

Drug NameLDC-1267

Drug Alias NameLDC-1267

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTYRO3 protein tyrosine kinase inhibitorsAXL receptor tyrosine kinase inhibitorsSerine/threonine-protein kinase Aurora inhibitors +[4]

TargetsTYRO3 protein tyrosine kinaseSerine/threonine-protein kinase AuroraAXL receptor tyrosine kinase +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLead Discovery Center Max Planck Innovation

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLead Discovery Center Max Planck Innovation

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A